Watchlist Price Alert

Hikma Pharmaceuticals (HKMPF)

PNK: HKMPF · Real-Time Price · USD

26.20

-0.36 (-1.36%)

At close: May 01, 2025, 8:00 PM

Hikma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	359M	190M	188M	421M	431M	486M	282M	-843M	155M
Depreciation & Amortization	197M	190M	182M	169M	125M	107M	99M	125M	105M
Stock-Based Compensation	27M	25M	22M	29M	27M	24M	21M	22M	22M
Other Working Capital	43M	131M	-49M	86M	13M	-34M	-21M	-4M	19M
Other Non-Cash Items	194M	211M	160M	48M	-92M	-121M	49M	1.12B	171M
Deferred Income Tax	n/a	n/a	76M	99M	200M	-20M	71M	-43M	138M
Change in Working Capital	-213M	-8M	-98M	-128M	-227M	-4M	-92M	21M	-160M
Operating Cash Flow	564M	608M	530M	638M	464M	472M	430M	443M	293M
Capital Expenditures	-165M	-169M	-138M	-145M	-172M	-119M	-107M	-107M	-122M
Cash Acquisitions	-150M	-105M	-380M	-17M	-60M	19M	27M	5M	-515M
Purchase of Investments	n/a	-27M	-15M	-3M	-5M	-6M	-4M	-10M	-17M
Sales Maturities Of Investments	n/a	1M	395M	6M	2M	14M	4M	5M	532M
Other Investing Acitivies	-66M	-33M	-469M	-79M	-48M	-59M	-16M	-39M	-41M
Investing Cash Flow	-381M	-333M	-607M	-238M	-283M	-151M	-96M	-151M	-695M
Debt Repayment	124M	-73M	430M	-83M	234M	-4M	-141M	-78M	153M
Common Stock Repurchased	n/a	n/a	-300M	n/a	-375M	n/a	n/a	n/a	n/a
Dividend Paid	-175M	-137M	-125M	-120M	-109M	-97M	-84M	-79M	-77M
Other Financial Acitivies	-137M	-127M	-63M	-84M	-48M	-54M	-53M	-63M	-57M
Financial Cash Flow	-188M	-337M	-58M	-287M	-298M	-155M	-278M	-220M	19M
Net Cash Flow	-17M	-65M	-156M	103M	-119M	166M	49M	72M	-398M
Free Cash Flow	399M	439M	392M	493M	292M	353M	323M	336M	171M